hydroxyurea has been researched along with 2019 Novel Coronavirus Disease in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Throughout the Coronavirus Disease 2019 (COVID-19) pandemic, understanding the effects of COVID-19 on persons with Sickle Cell Disease (SCD) and Sickle Cell Trait (SCT) has garnered interest." | 2.82 | COVID-19 outcomes in sickle cell disease and sickle cell trait. ( Christian, J; Lanzkron, S; Naik, RP, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 13 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yurtsever, N | 1 |
| Nandi, V | 1 |
| Ziemba, Y | 1 |
| Shi, PA | 1 |
| Hoogenboom, WS | 1 |
| Alamuri, TT | 1 |
| McMahon, DM | 1 |
| Balanchivadze, N | 1 |
| Dabak, V | 1 |
| Mitchell, WB | 2 |
| Morrone, KB | 1 |
| Manwani, D | 3 |
| Duong, TQ | 1 |
| Ben Moftah, M | 1 |
| Eswayah, A | 1 |
| Cai, J | 1 |
| Chen-Goodspeed, A | 1 |
| Idowu, M | 1 |
| Christian, J | 2 |
| Lanzkron, S | 2 |
| Naik, RP | 2 |
| DeBaun, MR | 1 |
| Nickel, RS | 1 |
| Margulies, S | 1 |
| Frazer, B | 1 |
| Luban, NLC | 1 |
| Webb, J | 1 |
| Novelli, EM | 1 |
| Chopra, J | 1 |
| Hiew, HJ | 1 |
| Cumpstey, A | 1 |
| Cagampang, F | 1 |
| Jenner, MW | 1 |
| Dushianthan, A | 1 |
| Morrone, KA | 1 |
| Strumph, K | 1 |
| Liszewski, MJ | 1 |
| Jackson, J | 1 |
| Rinke, ML | 1 |
| Silver, EJ | 1 |
| Minniti, C | 1 |
| Davila, J | 1 |
| Citron, F | 1 |
| Perelli, L | 1 |
| Deem, AK | 1 |
| Genovese, G | 1 |
| Viale, A | 1 |
| Minniti, CP | 1 |
| Zaidi, AU | 1 |
| Nouraie, M | 1 |
| Crouch, GD | 1 |
| Crouch, AS | 1 |
| Callaghan, MU | 1 |
| Carpenter, S | 1 |
| Jacobs, C | 1 |
| Han, J | 1 |
| Simon, J | 1 |
| Glassberg, J | 1 |
| Gordeuk, VR | 1 |
| Klings, ES | 1 |
| Patel, PA | 1 |
| Lapp, SA | 1 |
| Grubbs, G | 1 |
| Edara, VV | 1 |
| Rostad, CA | 1 |
| Stokes, CL | 1 |
| Pauly, MG | 1 |
| Anderson, EJ | 1 |
| Piantadosi, A | 1 |
| Suthar, MS | 1 |
| Khurana, S | 1 |
| Sabnis, HS | 1 |
2 reviews available for hydroxyurea and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
Topics: Adult; Anemia, Sickle Cell; Child; COVID-19; Humans; Hydroxyurea; SARS-CoV-2; Sickle Cell Trait | 2022 |
COVID-19 outcomes in sickle cell disease and sickle cell trait.
Topics: Anemia, Sickle Cell; COVID-19; Humans; Hydroxyurea; Risk Factors; Sickle Cell Trait | 2022 |
COVID-19 outcomes in sickle cell disease and sickle cell trait.
Topics: Anemia, Sickle Cell; COVID-19; Humans; Hydroxyurea; Risk Factors; Sickle Cell Trait | 2022 |
COVID-19 outcomes in sickle cell disease and sickle cell trait.
Topics: Anemia, Sickle Cell; COVID-19; Humans; Hydroxyurea; Risk Factors; Sickle Cell Trait | 2022 |
COVID-19 outcomes in sickle cell disease and sickle cell trait.
Topics: Anemia, Sickle Cell; COVID-19; Humans; Hydroxyurea; Risk Factors; Sickle Cell Trait | 2022 |
1 trial available for hydroxyurea and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Blood Donors; Blood Safety; Blood Transfusion; Chelation The | 2020 |
10 other studies available for hydroxyurea and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Prognostic factors associated with COVID-19 related severity in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; beta-Thalassemia; Child; COVID-19; Female; Genotype; Health Personnel; H | 2021 |
Repurposing of Hydroxyurea Against COVID-19: A Promising Immunomodulatory Role.
Topics: COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Hydroxyurea; SARS-CoV-2 | 2022 |
Risk and protective factors for severe COVID-19 infection in a cohort of patients with sickle cell disease.
Topics: Anemia, Sickle Cell; COVID-19; Humans; Hydroxyurea; Protective Factors; Retrospective Studies | 2022 |
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.
Topics: Anemia, Sickle Cell; Antisickling Agents; Blood Donors; Blood Safety; Blood Transfusion; Child; Chil | 2020 |
COVID-19 and SCA: an old friend comes to the rescue.
Topics: Betacoronavirus; Child; Coronavirus Infections; COVID-19; Friends; Humans; Hydroxyurea; Pandemics; P | 2020 |
Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia.
Topics: COVID-19; COVID-19 Drug Treatment; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Male; Mid | 2020 |
Acute chest syndrome in the setting of SARS-COV-2 infections-A case series at an urban medical center in the Bronx.
Topics: Acute Chest Syndrome; Adolescent; Anemia, Sickle Cell; Anti-Bacterial Agents; Antisickling Agents; C | 2020 |
Leukotrienes, a potential target for Covid-19.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betaco | 2020 |
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
Topics: Acute Chest Syndrome; Adult; Anemia, Sickle Cell; Antisickling Agents; COVID-19; Disease Progression | 2021 |
Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antimalarials; Antineoplastic Agents; Antiviral Agents | 2021 |